Crispr Therapeutics shares owned by Hudson Bay Capital Management
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Hudson Bay Capital Management
from 13F filings
Historical chart of Hudson Bay Capital Management investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Hudson Bay Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Hudson Bay Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-09-30 | $454k | 10k | 45.39 |
| 2023-06-30 | $1.7M | 30k | 56.14 |
| 2023-03-31 | $2.7M | 60k | 45.23 |
| 2022-12-31 | $3.3M | 82k | 40.65 |
| 2022-06-30 | $912k | 15k | 60.80 |
| 2022-03-31 | $2.2M | 35k | 62.77 |
| 2021-12-31 | $1.8M | 24k | 75.78 |
| 2021-09-30 | $2.0M | 18k | 111.94 |
| 2021-06-30 | $1.2M | 7.5k | 161.87 |
| 2021-03-31 | $1.8M | 15k | 121.87 |
More positions owned by Hudson Bay Capital Management
View all positions for Hudson Bay Capital Management